Pharmacokinetics of single dose intravenous infusion of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment | Journal of Shanghai Jiaotong University(Medical Science);(6)2006. | WPRIM

Contenido principal 1 Búsqueda 2 Pie de página 3

+A A -A Alto contraste

Pharmacokinetics of single dose intravenous infusion of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment / 上海第二医科大学学报

xiao-dong, YAO; jin-fang, SHEN; yi-min, MAO; min-de, ZENG.

Journal of Shanghai Jiaotong University(Medical Science) ; (6)2006.

Artículo en Chino | WPRIM | ID: wpr-640830

ABSTRACT

ABSTRACT

0.05). Conclusion The elimination half-life of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment is 27 h,and the regiment of 100 mg once a day is recommended.

magnesium isoglycyrrhizinate; pharmacokinetics; chronic hepatic impairment; intravenous infusion

Buscar en Google

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Journal of Shanghai Jiaotong University(Medical Science) Año: 2006 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Buscar en Google

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Journal of Shanghai Jiaotong University(Medical Science) Año: 2006 Tipo del documento: Artículo